NCT00316914 - Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity Caused By Oxaliplatin in Patients Receiving Combination Chemotherapy for Stage II, Stage III, or Stage IV Colorectal Cancer That Has Been Completely Removed By Surgery | Biotech Hunter

Enrollment

104

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

January 31, 2008

Study Completion Date

November 30, 2012

Conditions

Colorectal CancerNeurotoxicity

Interventions

DRUG

calcium gluconate

Given IV

DRUG

magnesium sulfate

Given IV

OTHER

placebo

Given IV

Trial Locations (14)

30912

MBCCOP - Medical College of Georgia Cancer Center, Augusta

50307

Mercy Capitol Hospital, Des Moines

50309

CCOP - Iowa Oncology Research Association, Des Moines

John Stoddard Cancer Center at Iowa Methodist Medical Center, Des Moines

Medical Oncology and Hematology Associates at John Stoddard Cancer Center, Des Moines

50314

Medical Oncology and Hematology Associates at Mercy Cancer Center, Des Moines

Mercy Cancer Center at Mercy Medical Center - Des Moines, Des Moines

50316

John Stoddard Cancer Center at Iowa Lutheran Hospital, Des Moines

57105

Avera Cancer Institute, Sioux Falls

Medical X-Ray Center, PC, Sioux Falls

58501

Bismarck Cancer Center, Bismarck

Medcenter One Hospital Cancer Care Center, Bismarck

Mid Dakota Clinic, PC, Bismarck

57117-5039

Sanford Cancer Center at Sanford USD Medical Center, Sioux Falls

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

collaborator

North Central Cancer Treatment Group

NETWORK

lead

Alliance for Clinical Trials in Oncology

OTHER